JPRN-UMIN000009094已完成未知
Pilot study of hepatic arterial infusion chemotherapy followed by sorafenib for advanced hepatocellular carcinoma - HICS 55
Department of Gastroenterology and Metabolism,Hiroshima University Hospital0 个研究点目标入组 55 人开始时间: 2012年10月11日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 55
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) With other malignant disease. 2) A pregnant woman, or a woman suspected of pregnancy. 3) With severe infectious disease. 4) With history of severe allergy. 5) With severe renal function disease. 6) With severe allergy for 5FU or CDDP. 7) With severe bone marrow supression. 8) Esophageal and/or gastric varices which has high risk of bleeding and clinically significant gastro- intestinal bleeding. 9) Serious hypertension 10) Any condition that is unstable or could jeopardize the safety of the patient and its compliance in the study, in the investigator's judgment.
研究者
相似试验
已完成
2 期
pilot study of hepatic arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma patients in Child-Pugh score 8,9advanced hepatocellular carcinomaJPRN-UMIN000009272Department of Gastroenterology and Metabolism,Hiroshima University Hospital30
已完成
1 期
A phase 1 trial of hepatic arterial infusion chemotherapy with high dose cisplatin and 5-fluorouracil for unresectable advanced and recurrent hepatocellular carcinomaJPRN-UMIN000015101Keio University, School of medicine, Department of Surgery18
已完成
不适用
Clinical trial of hepatic arterial infusion chemotherapy with multidrug resistance-associated protein 3-derived peptide for hepatocellular carcinomaHepatocellular carcinoma (HCC)JPRN-UMIN000005678Department of Gastroenterology, Kanazawa University Hospital12
已完成
1 期
Phase I study of hepatic arterial infusion chemotherapy with gemcitabine and 5FU for postoperative liver metastases from pancreatic cancer.Postoperative liver metastases from pancreatic cancerJPRN-UMIN000011059Department of Gastroenterologic Surgery, Kanazawa University12
已完成
1 期
A phase I,II trial of hepatic arterial infusion chemotherapy with cisplatin and 5-fluorouracil for unresectable advanced hepatocellular carcinomahepatocellular carcinomaJPRN-UMIN000013734Sapporo Medical University School of Medicine28